$732 Million is the total value of VR Adviser, LLC's 26 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 23.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| TIL | Instil Bio Inc | $117,461,000 | -4.3% | 6,865,076 | 0.0% | 16.06% | +1.9% | |
| ACRS | Aclaris Therapeutics Inc | $66,360,000 | -19.2% | 4,563,962 | 0.0% | 9.07% | -14.0% | |
| TVTX | Buy | Travere Therapeutics Inc | $61,925,000 | +47.4% | 1,994,997 | +15.2% | 8.46% | +56.9% |
| RLMD | Buy | Relmada Therapeutics Inc | $51,145,000 | +40.6% | 2,270,072 | +63.6% | 6.99% | +49.6% |
| GHRS | Buy | GH Research PLCord sh | $47,173,000 | +30.2% | 2,021,985 | +23.1% | 6.45% | +38.6% |
| Aadi Bioscience Inc | $36,935,000 | -17.8% | 1,529,402 | 0.0% | 5.05% | -12.5% | ||
| VRDN | Buy | Viridian Therapeutics Inc | $36,632,000 | +11311.8% | 1,852,919 | +9404.6% | 5.01% | +12114.6% |
| Buy | Marinus Pharmaceuticals Inc | $34,216,000 | +13.8% | 2,880,096 | +9.0% | 4.68% | +21.1% | |
| CLDX | Sell | Celldex Therapeutics Inc | $33,428,000 | -43.6% | 865,116 | -21.2% | 4.57% | -40.0% |
| TCDA | Buy | Tricida Inc | $33,411,000 | +1742.9% | 3,494,851 | +794.5% | 4.57% | +1860.1% |
| New | LianBiospons adr | $33,131,000 | – | 5,378,341 | +100.0% | 4.53% | – | |
| VTGN | VistaGen Therapeutics Inc | $31,292,000 | -28.8% | 16,047,286 | 0.0% | 4.28% | -24.3% | |
| KDNY | New | Chinook Therapeutics Inc | $20,939,000 | – | 1,283,821 | +100.0% | 2.86% | – |
| GRPH | Graphite Bio Inc | $20,045,000 | -24.2% | 1,612,617 | 0.0% | 2.74% | -19.3% | |
| Nuvalent Inc | $15,307,000 | -15.6% | 803,951 | 0.0% | 2.09% | -10.2% | ||
| KNTE | Sell | Kinnate Biopharma Inc | $13,698,000 | -59.6% | 773,014 | -47.5% | 1.87% | -57.0% |
| ATHA | Sell | Athira Pharma Inc | $13,030,000 | +16.1% | 1,000,000 | -16.4% | 1.78% | +23.6% |
| CNTA | Centessa Pharmaceuticals PLCspons adr | $12,693,000 | -32.6% | 1,127,272 | 0.0% | 1.74% | -28.2% | |
| LIFE | aTyr Pharma Inc | $11,691,000 | -17.7% | 1,565,000 | 0.0% | 1.60% | -12.4% | |
| COGT | Cogent Biosciences Inc | $9,342,000 | +2.0% | 1,088,817 | 0.0% | 1.28% | +8.6% | |
| AFMD | New | Affimed NV | $7,886,000 | – | 1,428,571 | +100.0% | 1.08% | – |
| OLMA | Sell | Olema Pharmaceuticals Inc | $7,644,000 | -81.9% | 816,651 | -46.8% | 1.04% | -80.8% |
| CVRX | CVRx Inc | $6,523,000 | -26.1% | 533,370 | 0.0% | 0.89% | -21.3% | |
| AKYA | Akoya Biosciences Inc | $6,124,000 | +9.7% | 400,000 | 0.0% | 0.84% | +16.7% | |
| Astria Therapeutics Inc | $2,905,000 | -39.0% | 538,999 | 0.0% | 0.40% | -35.1% | ||
| CRVS | Sell | Corvus Pharmaceuticals Inc | $603,000 | -96.4% | 250,000 | -92.7% | 0.08% | -96.2% |
| PHVS | Exit | PHARVARIS NV | $0 | – | -552,882 | -100.0% | -1.26% | – |
| CGEM | Exit | CULLINAN ONCOLOGY INC | $0 | – | -706,050 | -100.0% | -2.05% | – |
| ALT | Exit | ALTIMMUNE INC | $0 | – | -3,800,000 | -100.0% | -5.52% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ACLARIS THERAPEUTICS INC | 12 | Q3 2023 | 12.7% |
| VIRIDIAN THERAPEUTICS INC | 12 | Q3 2023 | 13.4% |
| COGENT BIOSCIENCES INC | 12 | Q3 2023 | 10.3% |
| RELMADA THERAPEUTICS INC | 11 | Q3 2022 | 9.9% |
| GH RESEARCH PLC | 10 | Q3 2023 | 6.7% |
| ALTIMMUNE INC | 9 | Q3 2022 | 11.6% |
| MARINUS PHARMACEUTICALS INC | 9 | Q4 2022 | 5.7% |
| CELLDEX THERAPEUTICS INC | 9 | Q3 2022 | 7.6% |
| AFFIMED N V | 8 | Q3 2023 | 1.1% |
| INSTIL BIO INC | 7 | Q3 2022 | 18.7% |
View VR Adviser, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR/A | 2023-05-15 |
| 13F-HR/A | 2023-05-15 |
| 13F-HR/A | 2023-05-15 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
View VR Adviser, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.